FIELD: virology. SUBSTANCE: invention relates to the strain of avian influenza A virus. Proposed strain, in contrast to other strains with subtype of hemagglutinine H5, shows no pathogenicity for birds and humans. Adapted strain is obtained by passages of the parent virus A/mallard duck/Pennsylvania/10218/84 (H5N2) through white mice lungs. Obtained strain is designated for research of genetic bases of interspecies barrier overcoming, detection of phylogenetic and ecological association of viruses isolated for different times in different geographic regions. Claimed influenza virus damages mouse lung that are identified as viral bronchopneumonia that resembles by many traits with human viral bronchopneumonia. Strain of avian influenza A virus (H5N2) is stored in collection of laboratory of museum strains of Institute of virology RAMS-GKV at N 2340. EFFECT: strain of influenza virus A indicated above, valuable properties. 3 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STRAIN OF AVIAN INFLUENZA VIRUS A(H2N3)ГКВ 2237 FOR VIRAL INFECTION MODELLING | 1991 |
|
RU2021354C1 |
| STRAIN A/CHIKEN/KOSTROMA/3175/17 H5N2 OF AVIAN INFLUENZA VIRUS SUBTYPE H5N2 INFUENZA A VIRUS OF GENUS ALPHAINFLUENZAVIRUS TO CONTROL ANTIGENIC AND IMMUNOGENIC ACTIVITY OF AVIAN INFLUENZA VACCINES AND FOR MAKING ANTIGEN-CONTAINING DIAGNOSTICUMS | 2020 |
|
RU2736788C1 |
| INFLUENZA VIRUS STRAIN A/JAPAN/1/57(H2N1) FOR MODELING INFECTION IN MICE | 0 |
|
SU1735363A1 |
| REASSORTANT RN2/57-HUMAN A(H7N2) INFLUENZA VIRUS STRAIN FOR NEURAMINIDASE ANTIBODY ASSAY IN INFLUENZA INFECTION AND VACCINATION | 2011 |
|
RU2464312C1 |
| STRAIN OF INFLUENZA VIRUS GKV 2389 FOR PRODUCTION OF LIVING INTRANASAL AND INACTIVATED INFLUENZA VACCINE | 2006 |
|
RU2318871C1 |
| REASSORTANT RN A9-SWINE A(H7N1) INFLUENZA VIRUS STRAIN FOR NEURAMINIDASE ANTIBODY ASSAY IN INFLUENZA INFECTION AND VACCINATION | 2010 |
|
RU2428476C1 |
| STRAIN OF INFLUENZA VIRUS A/17/MALLARD/NETHERLANDS/00/95(H7N3) FOR PRODUCTION OF LIVE AND INACTIVATED INFLUENZA VACCINES | 2012 |
|
RU2507256C2 |
| ANTI-FLU NANOANTIBODY, RECOMBINANT VIRAL VECTORS AND PHARMACEUTICAL COMPOSITIONS FOR PROPHYLAXIS AND THERAPY OF A-TYPE FLU | 2011 |
|
RU2502745C2 |
| STRAIN OF HYBRID CULTIVATED MURINE CELLS Mus Musculus - 4F11 PRODUCING MONOCLONAL ANTIBODY RESPONDER WITH HEMAGGLUTININ PROTEIN OF HIGH-PATHOGEN STRAIN virus A/duck/Novosibirsk/56/05 H5N1 | 2008 |
|
RU2384617C1 |
| STRAIN OF HYBRID CULTIVATED MURINE CELLS Mus Musculus-6F3 PRODUCING MONOCLONAL ANTIBODY NONTOLERANT TO HEMAGGLUTININ PROTEIN OF HIGH-PATHOGEN STRAIN virus A/duck/Novosibirsk/56/05 H5N1 | 2008 |
|
RU2385929C1 |
